Gilead hepatitis agent
Executive Summary
Gilead selects Hepsera as U.S. trade name for hepatitis B treatment adefovir dipivoxil. User fee deadline for Hepsera is Sept. 21 (1"The Pink Sheet" Aug. 12, p. 3)...
Gilead selects Hepsera as U.S. trade name for hepatitis B treatment adefovir dipivoxil. User fee deadline for Hepsera is Sept. 21 (1 (Also see "Gilead Adefovir Patients Should Be Monitored Every Four Weeks - FDA Cmte." - Pink Sheet, 12 Aug, 2002.), p. 3).... |